S100B and Brain atrophy: Some authors found that serum S100b concentrations were similar (126) or lower in CSF of AD patients compared with elderly controls, not correlating with brain atrophy (127), whereas others reported correlations between CSF S100b levels and AD brain atrophy or cognitive status as measured by the Mini Mental State Exam score (128, 129).